Cargando…

Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.

Lymphocyte homing receptor (CD44) is involved in lymphocyte adhesion to endothelial cells of high endothelial venules (HEVs) and lymphocyte exit from the blood circulation, and it may be involved also in hematogenous dissemination of malignant lymphoma. Prognostic significance of lymphocyte homing r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joensuu, H., Ristamäki, R., Klemi, P. J., Jalkanen, S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1993
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968534/ https://www.ncbi.nlm.nih.gov/pubmed/8347502

Ejemplares similares

Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
por: Klemi, P. J., et al.
Publicado: (1992)

Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.
por: Inki, P., et al.
Publicado: (1994)

Histological features, DNA content and prognosis of breast carcinoma found incidentally or in screening.
por: Joensuu, H., et al.
Publicado: (1991)

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells
Publicado: (1991)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
por: Si, Daolin, et al.
Publicado: (2020)

CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
por: Cao, Xueyuan, et al.
Publicado: (2014)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
por: Wu, Cheng-Lin, et al.
Publicado: (2015)

Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon
Publicado: (1995)

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.
por: Toikkanen, S., et al.
Publicado: (1989)

CD44(+)/CD24(−) phenotype predicts a poor prognosis in triple-negative breast cancer
por: Wang, Hui, et al.
Publicado: (2017)

High CD8(+)tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma
por: Zhu, Qiqi, et al.
Publicado: (2023)

CD44 Variant Isoform Expression and Breast Cancer Prognosis
por: Tokue, Yutaka, et al.
Publicado: (1998)

High expression of Dll4 and CD44V6 is associated with clinicopathological characteristics and poor prognosis in osteosarcoma patients
por: Xie, Haiyang, et al.
Publicado: (2021)

Anaplastic lymphoma kinase expression in PDGFRA-mutated gastrointestinal stromal tumors probably correlates with poor prognosis
por: Wu, Ying, et al.
Publicado: (2023)

CD44 is a potential immunotherapeutic target and affects macrophage infiltration leading to poor prognosis
por: Liu, Shuangqing, et al.
Publicado: (2023)

Decreased peripheral CD4(+)/CD8(+ )lymphocytes and poor prognosis in aged sepsis
por: Inoue, S, et al.
Publicado: (2012)

Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44
Publicado: (1993)

Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages
Publicado: (1991)

CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
por: Tempfer, C., et al.
Publicado: (1998)

The Role of CD44 in the Pathophysiology of Chronic Lymphocytic Leukemia
por: Gutjahr, Julia Christine, et al.
Publicado: (2015)

The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas
por: Maula, S, et al.
Publicado: (2001)

Elevated preoperative neutrophil-to-lymphocyte ratio is associated with poor prognosis in gastrointestinal stromal tumor patients
por: Jiang, Chang, et al.
Publicado: (2016)

Correlation of PKM2 and CD44 Protein Expression with Poor Prognosis in Platinum-Treated Epithelial Ovarian Cancer: A Retrospective Study
por: Papadaki, Chara, et al.
Publicado: (2020)

CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
por: Tjhay, Francisca, et al.
Publicado: (2015)

CD44v6 overexpression related to metastasis and poor prognosis of colorectal cancer: A meta-analysis
por: Wang, Ji-Lin, et al.
Publicado: (2016)

CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression
por: Xiao, Yong, et al.
Publicado: (2022)

CD5-negative chronic lymphocytic leukemia/small lymphocytic lymphoma in a patient with gastrointestinal mantle cell lymphoma: an unusual case report
por: Chen, Dangui, et al.
Publicado: (2019)

CD44(+)CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
por: Hurt, E M, et al.
Publicado: (2008)

Mammography screening interval and the frequency of interval cancers in a population-based screening.
por: Klemi, P. J., et al.
Publicado: (1997)

Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma
por: Lee, Hye-Jin, et al.
Publicado: (2015)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis of patients with primary gastrointestinal stromal tumor
por: Chang, Wei-Long, et al.
Publicado: (2020)

CXCR4, CXCR5 and CD44 May Be Involved in Homing of Lymphoma Cells into the Eye in a Patient Derived Xenograft Homing Mouse Model for Primary Vitreoretinal Lymphoma
por: Babst, Neele, et al.
Publicado: (2022)

Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors
por: Zhuang, Chun, et al.
Publicado: (2023)

CD44(+) cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer
por: Szczepanik, Antoni, et al.
Publicado: (2018)

Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Liu, Yue, et al.
Publicado: (2022)

Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma
por: Eberth, Sonja, et al.
Publicado: (2010)

Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas
por: Zhou, Dang-xia, et al.
Publicado: (2012)

High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma
por: Louis-Brennetot, Caroline, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lj7tabgjvppdl9a098hq7k7ba4